Scientific Output
Publications & Research
Patents, peer-reviewed articles, and research publications from the Summit Life Science team and SEDDS Technology Research Lab fellows spanning drug delivery systems, formulation science, and bioavailability enhancement.
14+
Key Publications & Patents
10+
Patents Filed
65+
Peer-Reviewed Articles
60+
Invited Presentations
Publications
Patents & Research Papers
Selected patents and peer-reviewed publications from the Summit Life Science research team, covering self-emulsifying drug delivery systems, formulation sciences, and clinical research.
US Patent Series No. 60/607, 320. J Wang, P. Gao, GW Lu: Self Emulsifying Composition For Delivering Lipophilic Active Ingredients.
Chinese Patent ZL2005 8 0029556.2 王小曾 用自乳化制剂释放亲脂性辅酶CoQ10及其他膳食组份.
US 6,121,313. P.Gao and W.Morozowich. Pharmaceutical composition in a form of self-emulsifying formulation for acidic lipophilic compounds.
US 6,231,887 B1. P.Gao and W.Morozowich. Pharmaceutical composition for lipophilic compounds in a form of self-emulsifying formulation.
US 6,451,838 B1. M.W.Moon, W.Morozowich, P.Gao. 1-(pyrrolidin-1-ylmethyl)-3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives.
US 6,482,848 B2. Prodrugs of 3-(pyrrol-2-yl-methylidene)-2-indolinone derivatives by M.W.Moon, W.Morozowich, P.Gao, M.Koenig.
US 6,531,139 B1. P.Gao, W.Morozowich. Self-emulsifying formulation for lipophilic compounds.
US 6,579,895 B2. A.Karim, A.M.Brugger, P.Gao, F.Hassan, and J.C.Forbes. Use of a celecoxib composition for fast pain relief.
EP 0989 851 B1. W.Morozowich and P.Gao. Self-emulsifying formulation for acidic lipophilic compounds.
EP 0999 838 B1. W.Morozowich and P.Gao. Self-emulsifying formulation for lipophilic compounds.
WO 01/90068 A2. Mannich base prodrug of 3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives by M.W.Moon, W.Morozowich, P.Gao, P.C.Tang.
WO 01/90104 A2. Prodrugs of 3-(pyrrol-2-yl-methylidene)-2-indolinone derivatives by M.W.Moon, W.Morozowich, P.Gao.
Yunguo Gong, Chaoneng Wu, Qinghe Xing, Xinzhi Zhao, Jun Zhu, Lin He. A two-method Meta analysis of Neuregulin 1 (NRG1) association and heterogeneity in schizophrenia. Schizophrenia Research. 2009, 111 (1-3):109-114. (Research article, IF4.6, cited times 36)
Chaoneng Wu, Yunguo Gong, Jie Yuan, Hui Gong, Yunzeng Zou, Junbo Ge. Identification of shared genetic susceptibility locus for coronary artery disease, type 2 diabetes and obesity: a meta-analysis of genome-wide studies. Cardiovasc Diabetol. 2012, 14;11 (1):68-80. (Research article, co-first author, IF4.0, cited times 6)
Research Fellows
The Scientists Behind the Science
Our research fellows are experienced scientists from top pharmaceutical companies and universities, collectively holding dozens of patents and hundreds of publications in drug delivery and formulation science.
Dr. Jimmy X. Wang
Ph.D., NYU Polytechnic University
Highlights
- 10+ patents filed
- 100+ publications and presentations
- 50+ new products approved and sold in the US market
- Founder: MTC Industries, AHF, and Summit Life Science
As a senior chemist and continuous entrepreneur, Dr. Wang's expertise includes comprehensive knowledge, skills and experience in APIs, IPIs, formulations, analytic method validation development, animal and human clinical studies and protocol designs.
FDA compliance for DMF, DS, MF, OTC, ANDA, NDA regulatory affairs and GMP facility inspection, pre-audit.
Solid & liquid dosage form development of specialty drug delivery system in the SEDDS technology field of formulation/process design, development, scale-up, optimization and process validation.
He successfully built up leading Nutraceutical Operations for the AHF companies at 4 different locations and implemented the products development driven and cost-effective program. Dr. Wang successfully managed and supervised scientists to develop and design various products for multiple compounds and formulations including more than 50 new products approved and sold in the US market.
Dr. Jimmy X. Wang obtained BS degree from Nanjing Normal University in 1982, followed by MS degree and Ph.D. degree in Chemistry from NYU Polytechnic University in New York in 1991. After graduating from NYU Poly, he joined DuPont Pharmaceuticals as a senior chemist and then worked with a FDA Regulatory consulting firm as a senior scientist. Dr. Wang has more than 10 patents and over hundreds of publications and presentations.
Dr. Ping "Peter" Gao
Ph.D., Analytical Chemistry, Purdue University (1988)
Highlights
- AAPS Fellow (2009)
- 24 granted US/European patents
- 65 peer-reviewed publications
- Inventor of tipranavir (HIV) and dasabuvir (HCV) formulations
Retired from AbbVie in July 2019 at the position of Center Director, Research Fellow, NCE-Formulation. 27+ years of technical service at Pharmaceutical companies including Upjohn, Pharmacia, Pfizer, Amgen and Abbott/AbbVie.
Scientific and technical expertise: biopharmaceutics property assessment and preformulation for tox and FIH, formulation sciences and manufacturing processes, enabling drug delivery technologies for poorly soluble drugs, biorelevant in vitro assessment of formulation performance for BA and BE, quantitative in vitro-in vivo relationships.
Inventor of formulation in marketed products: tipranavir (HIV) and dasabuvir (HCV) with high drug loading and excellent bioavailability.
Inventor/co-inventor of 24 granted US/European patents and 25 patent applications. 65 publications including peer-reviewed journal articles/book chapters, guest editors for Mol. Pharm. and AAPS J. and 60+ invited presentations at NIH, FDA, national and international conferences, workshops and short courses, and universities.
Elected as Fellow of American Association of Pharmaceutical Scientists (AAPS) in 2009. AAPS Physical Pharmacy & Biopharmaceutics (PPB) Section Chair/vice chair: 2012–2014.
Dr. Li Yao
Ph.D.
Highlights
- cGMP/cGLP expertise
- FDA laboratory regulatory compliance
- Analytical R&D leadership
Has a strong cGMP/cGLP knowledge with experience in implementing FDA regulations applicable to laboratories in pharmaceutical settings.
Director of Analytical R&D & Quality Control at Summit Life Science, Dr. Yao brings deep regulatory and analytical expertise to ensure product quality and compliance across all research programs.